Product Information

SHAROBEL 0.35 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.0906 per EA under NDC 16714044104. Its NADAC has been published 616 times since Nov 5, 2014.

FDA first approved this application on Sep 13, 2013. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SHAROBEL 0.35 MG TABLET

Norethindrone
$0.0906per EA

Manufacturer

NorthStar Rx LLC

NDC

16714044104

Classification

Generic

Dosage Form

KIT

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA200961

FDA Approved

9/13/2013

TE Code

AB2

On Market Since

9/13/2013

Price Statistics

The NADAC for SHAROBEL 0.35 MG TABLET has been published 616 times since Nov 5, 2014, and over the history we have for it it has declined 84.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0906 per EA
All-time high$0.6358 (Dec 10, 2014)
All-time low$0.0691 (Nov 20, 2024)
52-week high$0.0945
52-week low$0.0849
Median price$0.2042
Average price$0.2382
Largest weekly change+43.4% (Aug 21, 2024)
Weeks tracked616
Tracking sinceNov 5, 2014

Price History

1W

-2.7%

1M

-2.7%

3M

-3.9%

6M

-2.8%

1Y

+2.2%

3Y

-31.9%

5Y

-49.5%

All

-84.4%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of SHAROBEL 0.35 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SHAROBEL 0.35 MG TABLET, manufactured by NorthStar Rx LLC, is $0.0906 per EA (NDC 16714044104), effective Aug 19, 2026.

How has the price of SHAROBEL 0.35 MG TABLET changed over time?

Over the history we have for it, the NADAC for SHAROBEL 0.35 MG TABLET has declined 84.4%. It has been tracked across 616 weekly CMS publications since Nov 5, 2014.

What are the highest and lowest recorded NADAC prices for SHAROBEL 0.35 MG TABLET?

Since Nov 5, 2014, the NADAC for SHAROBEL 0.35 MG TABLET has ranged from a low of $0.0691 (Nov 20, 2024) to a high of $0.6358 (Dec 10, 2014), with a median of $0.2042 per EA.

Are there cheaper alternatives to SHAROBEL 0.35 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as SHAROBEL 0.35 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures SHAROBEL 0.35 MG TABLET?

SHAROBEL 0.35 MG TABLET (NDC 16714044104) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.